105 related articles for article (PubMed ID: 10971744)
21. Cerebral amyloid β(42) deposits and microvascular pathology in ageing baboons.
Ndung'u M; Härtig W; Wegner F; Mwenda JM; Low RW; Akinyemi RO; Kalaria RN
Neuropathol Appl Neurobiol; 2012 Aug; 38(5):487-99. PubMed ID: 22126319
[TBL] [Abstract][Full Text] [Related]
22. Probing amyloid-β pathology in transgenic Alzheimer's disease (tgArcSwe) mice using MALDI imaging mass spectrometry.
Carlred L; Michno W; Kaya I; Sjövall P; Syvänen S; Hanrieder J
J Neurochem; 2016 Aug; 138(3):469-78. PubMed ID: 27115712
[TBL] [Abstract][Full Text] [Related]
23. Codeposition of cystatin C with amyloid-beta protein in the brain of Alzheimer disease patients.
Levy E; Sastre M; Kumar A; Gallo G; Piccardo P; Ghetti B; Tagliavini F
J Neuropathol Exp Neurol; 2001 Jan; 60(1):94-104. PubMed ID: 11202179
[TBL] [Abstract][Full Text] [Related]
24. Late age increase in soluble amyloid-beta levels in the APP23 mouse model despite steady-state levels of amyloid-beta-producing proteins.
Janssen L; Keppens C; De Deyn PP; Van Dam D
Biochim Biophys Acta; 2016 Jan; 1862(1):105-12. PubMed ID: 26542217
[No Abstract] [Full Text] [Related]
25. High sensitivity analysis of amyloid-beta peptide composition in amyloid deposits from human and PS2APP mouse brain.
Güntert A; Döbeli H; Bohrmann B
Neuroscience; 2006 Dec; 143(2):461-75. PubMed ID: 17008022
[TBL] [Abstract][Full Text] [Related]
26. Alzheimer's disease.
De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
[TBL] [Abstract][Full Text] [Related]
27. Microglial response to LPS increases in wild-type mice during aging but diminishes in an Alzheimer's mouse model: Implication of TLR4 signaling in disease progression.
Go M; Kou J; Lim JE; Yang J; Fukuchi KI
Biochem Biophys Res Commun; 2016 Oct; 479(2):331-337. PubMed ID: 27641666
[TBL] [Abstract][Full Text] [Related]
28. In vivo seeding and cross-seeding of localized amyloidosis: a molecular link between type 2 diabetes and Alzheimer disease.
Oskarsson ME; Paulsson JF; Schultz SW; Ingelsson M; Westermark P; Westermark GT
Am J Pathol; 2015 Mar; 185(3):834-46. PubMed ID: 25700985
[TBL] [Abstract][Full Text] [Related]
29. Relationship between ubiquilin-1 and BACE1 in human Alzheimer's disease and APdE9 transgenic mouse brain and cell-based models.
Natunen T; Takalo M; Kemppainen S; Leskelä S; Marttinen M; Kurkinen KMA; Pursiheimo JP; Sarajärvi T; Viswanathan J; Gabbouj S; Solje E; Tahvanainen E; Pirttimäki T; Kurki M; Paananen J; Rauramaa T; Miettinen P; Mäkinen P; Leinonen V; Soininen H; Airenne K; Tanzi RE; Tanila H; Haapasalo A; Hiltunen M
Neurobiol Dis; 2016 Jan; 85():187-205. PubMed ID: 26563932
[TBL] [Abstract][Full Text] [Related]
30. Lack of P-glycoprotein Results in Impairment of Removal of Beta-Amyloid and Increased Intraparenchymal Cerebral Amyloid Angiopathy after Active Immunization in a Transgenic Mouse Model of Alzheimer's Disease.
Bruckmann S; Brenn A; Grube M; Niedrig K; Holtfreter S; von Bohlen und Halbach O; Groschup M; Keller M; Vogelgesang S
Curr Alzheimer Res; 2017; 14(6):656-667. PubMed ID: 27915995
[TBL] [Abstract][Full Text] [Related]
31. Transgenic expression of β1 antibody in brain neurons impairs age-dependent amyloid deposition in APP23 mice.
Paganetti P; Reichwald J; Bleckmann D; Abramowski D; Ammaturo D; Barske C; Danner S; Molinari M; Müller M; Papin S; Rabe S; Schmid P; Staufenbiel M
Neurobiol Aging; 2013 Dec; 34(12):2866-78. PubMed ID: 23870837
[TBL] [Abstract][Full Text] [Related]
32. Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein.
Maia LF; Kaeser SA; Reichwald J; Hruscha M; Martus P; Staufenbiel M; Jucker M
Sci Transl Med; 2013 Jul; 5(194):194re2. PubMed ID: 23863834
[TBL] [Abstract][Full Text] [Related]
33. Amyloid beta (Aβ) protein- and amyloid precursor protein (APP)-immunoreactive structures in the brains of aged tree shrews.
Yamashita A; Fuchs E; Taira M; Hayashi M
Curr Aging Sci; 2010 Dec; 3(3):230-8. PubMed ID: 20735344
[TBL] [Abstract][Full Text] [Related]
34. Fibrillar amyloid-beta production, accumulation, and recycling in transgenic mice pancreatic acinar cells and macrophages.
Wegiel J; Wisniewski HM; Muzylak M; Tarnawski M; Badmajew E; Nowakowski J; Wang KC; Shoji M; Mondadori C; Giovanni A
Amyloid; 2000 Jun; 7(2):95-104. PubMed ID: 10842711
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E is essential for amyloid deposition in the APP(V717F) transgenic mouse model of Alzheimer's disease.
Bales KR; Verina T; Cummins DJ; Du Y; Dodel RC; Saura J; Fishman CE; DeLong CA; Piccardo P; Petegnief V; Ghetti B; Paul SM
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):15233-8. PubMed ID: 10611368
[TBL] [Abstract][Full Text] [Related]
36. High levels of circulating beta-amyloid peptide do not cause cerebral beta-amyloidosis in transgenic mice.
Fukuchi K; Ho L; Younkin SG; Kunkel DD; Ogburn CE; LeBoeuf RC; Furlong CE; Deeb SS; Nochlin D; Wegiel J; Wisniewski HM; Martin GM
Am J Pathol; 1996 Jul; 149(1):219-27. PubMed ID: 8686746
[TBL] [Abstract][Full Text] [Related]
37. Microglial response to increasing amyloid load saturates with aging: a longitudinal dual tracer in vivo μPET-study.
Blume T; Focke C; Peters F; Deussing M; Albert NL; Lindner S; Gildehaus FJ; von Ungern-Sternberg B; Ozmen L; Baumann K; Bartenstein P; Rominger A; Herms J; Brendel M
J Neuroinflammation; 2018 Nov; 15(1):307. PubMed ID: 30400912
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial dysfunction in a transgenic mouse model expressing human amyloid precursor protein (APP) with the Arctic mutation.
Rönnbäck A; Pavlov PF; Mansory M; Gonze P; Marlière N; Winblad B; Graff C; Behbahani H
J Neurochem; 2016 Feb; 136(3):497-502. PubMed ID: 26500157
[TBL] [Abstract][Full Text] [Related]
39. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
40. Interplay between age, cerebral small vessel disease, parenchymal amyloid-β, and tau pathology: longitudinal studies in hypertensive stroke-prone rats.
Schreiber S; Drukarch B; Garz C; Niklass S; Stanaszek L; Kropf S; Bueche C; Held F; Vielhaber S; Attems J; Reymann KG; Heinze HJ; Carare RO; Wilhelmus MM
J Alzheimers Dis; 2014; 42 Suppl 3():S205-15. PubMed ID: 24825568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
